SK Mohanty, A Satapathy, MM Naidu… - Diagnostic …, 2020 - Springer
Background The world is currently witnessing a major devastating pandemic of Coronavirus disease-2019 (COVID-19). This disease is caused by a novel coronavirus named Severe …
At the time of writing this article, the world population is suffering from more than 2 million registered COVID-19 disease epidemic-induced deaths since the outbreak of the corona …
A Roshdy, S Zaher, H Fayed… - Frontiers in cardiovascular …, 2021 - frontiersin.org
Importance: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-associated cardiac injury has been postulated secondary to several mechanisms. While tissue …
CJ Clancy, IS Schwartz, B Kula… - Open Forum Infectious …, 2021 - academic.oup.com
Background Limited clinical data suggest a~ 16% prevalence of bacterial superinfections among critically ill patients with coronavirus disease 2019 (COVID-19). Methods We …
BE Kula, CJ Clancy, MH Nguyen, IS Schwartz - The Lancet Microbe, 2021 - thelancet.com
Invasive mould disease (IMD) might affect up to a third of critically ill patients with COVID-19. COVID-19-associated pulmonary aspergillosis (CAPA) is typically diagnosed on the basis of …
R Almamlouk, T Kashour, S Obeidat, MC Bois… - Clinical Microbiology …, 2022 - Elsevier
Background Many postmortem studies address the cardiovascular effects of COVID-19 and provide valuable information, but are limited by their small sample size. Objectives The aim …
R Janssen, MPJ Visser, ASM Dofferhoff… - British Journal of …, 2021 - cambridge.org
Coronavirus disease 2019 (Covid-19), caused by severe acute respiratory syndrome coronavirus (SARS-CoV)-2, exerts far-reaching effects on public health and socio-economic …
X Wang, J Lei, Z Li, L Yan - Frontiers in Medicine, 2021 - frontiersin.org
The coronaviruses that cause notable diseases, namely, severe acute respiratory syndrome (SARS), middle east respiratory syndrome (MERS) and coronavirus disease 2019 (COVID …
JC Kariyawasam, U Jayarajah… - The American journal …, 2022 - ncbi.nlm.nih.gov
COVID-19, a respiratory viral infection, has affected 388 million individuals worldwide as of the February 4, 2022. In this review, we have outlined the important liver manifestations of …